This bill requires New Jersey public school districts to obtain and maintain ready-to-use glucagon rescue therapy for students with diabetes who may experience severe low blood sugar. It authorizes trained school employees to administer this medication in emergencies when authorized by a student's individualized emergency health care plan, covering settings including classrooms, buses, and offsite activities. The legislation also provides legal protection for school staff acting in good faith when administering the medication and clarifies that using syringes for this purpose does not violate existing drug possession laws.
This bill requires New Jersey's Department of Health to create a program that buys and distributes xylazine test strips to organizations authorized to provide harm reduction services. The Department will manage bulk purchases, distribute the strips upon request from these organizations, and maintain a website to inform the public about xylazine and where to access the test strips. The program will be funded through available federal funds and state appropriations from the General Fund. This legislation takes effect immediately upon passage.
This bill creates a program allowing family members or approved third parties to become certified home health aides and provide care to older adults enrolled in Medicaid or NJ FamilyCare. Under the program, eligible individuals aged 65 or older would receive services through home care agencies, with the agency covering all certification training costs and prohibiting repayment from the caregiver. Services provided by these certified family members would be reimbursed at a rate of at least $30 per hour, with tasks limited to those a registered nurse can delegate to certified aides. The Division of Medical Assistance and Health Services must establish the program within six months and develop tools to identify eligible enrollees.
This bill amends the New Jersey Board of Nursing by updating the composition, qualifications, and duties of its members. It requires specific professional experience and residency requirements for board members, including registered nurses, licensed practical nurses, nurse educators, and an advanced practice nurse. The legislation also outlines the board's powers to examine applicants, issue licenses, and investigate violations of nursing regulations.
This Senate resolution urges the federal government to create a permanent WIC waiver program that would allow states to let participants use their benefits to buy different brands and types of infant formula during public emergencies. The bill directly affects low-income families in New Jersey and other states who rely on the WIC program for infant nutrition, particularly those who use formula because they cannot breastfeed. It seeks to prevent future shortages from leaving parents without access to necessary formula by giving state agencies flexibility to authorize alternative products when supply chains are disrupted. The resolution is a formal request to the USDA to establish this waiver system, which would be activated only when emergencies threaten infant formula availability.
This bill designates September of each year as "Alopecia Areata Awareness Month" in New Jersey to increase public understanding of the condition and support for those affected. It requires the Governor to issue an annual proclamation encouraging public officials, healthcare professionals, and citizens to participate in awareness activities and programs. The resolution aims to promote education about alopecia areata, an autoimmune disease that causes hair loss, and encourages increased research and funding for treatment and potential cures.
This bill authorizes New Jersey's Department of Health to establish partnerships in international public health, specifically seeking participation in the World Health Organization's Global Outbreak Alert and Response Network. The legislation directs the department to communicate with the network, submit applications, designate contact points, and engage in technical consultations and information-sharing activities to improve outbreak preparedness. It clarifies that the state does not join the World Health Organization itself and ensures no confidential health information is disclosed beyond existing legal protections. The law also confirms that the department cannot spend funds beyond what has already been appropriated for these activities.
This bill clarifies that testosterone therapy is covered under New Jersey's existing Menopause Coverage Act, which requires health insurance plans to cover medically necessary treatments for perimenopause and menopause. The legislation specifically ensures that insurance providers cannot deny coverage for testosterone therapy if it is prescribed by a medical provider, even if the federal Food and Drug Administration has not approved it for menopause treatment. It applies to hospital and medical service corporation contracts issued or renewed in New Jersey after the act's effective date. The bill also mandates that insurers provide clear information to subscribers about covered menopause treatments.
This bill requires long-term care facilities in New Jersey that specialize in Alzheimer's disease care to meet minimum staffing levels and maintain trained staff members available at all times. It mandates that facilities establish training programs for memory care therapy and annually certify compliance with enrichment activities and safety standards. The legislation also requires facilities to publicly report staffing numbers, describe Alzheimer's-specific activities, and submit annual data on antipsychotic medication use, while the state will conduct third-party reviews to identify and address excessive medication prescribing.
This bill designates the month of May each year as "Emotional and Behavioral Disorder Awareness Month" in New Jersey to promote public understanding of mental health conditions. The measure directly affects state officials, who would issue annual proclamations encouraging citizens and public agencies to participate in awareness activities during May. By establishing this official observance, the bill aims to reduce stigma and increase recognition of emotional and behavioral disorders without mandating specific programs or funding. The resolution takes effect immediately upon passage and serves primarily as a symbolic designation rather than creating new legal requirements.
